Find your path to Katie
3,083 people in our graph share verified history with Katie — schools, employers, funds. One of them is your warm intro.
Ben RobbinsunlockedKatie: together at Harvard Business School (2014–2015)
×11Katie: together at Harvard Business School
About
Katie Hewitt is SVP Business Development and CBO Genetic Medicines at Alloy Therapeutics, Inc. She spent over 25 years at Eli Lilly, advancing from financial analysis to Global Head of Business Development for Lilly Catalyze, with roles spanning transactions, platform technology, and digital health. She has also served on the boards of biotechnology companies.
Experience
- Alloy Therapeutics, Inc.SVP Business Development & CBO Genetic Medicinescurrent2025 — present
- BlueYard CapitalVenture Partnercurrent2025 — present
- Aakha BiologicsCBOcurrent2026 — present
- Sensible BiotechnologiesVice President of Business Developmentcurrent2025 — present
- Orion BiotechnologyBoard Membercurrent2025 — present
- DUB TherapeuticsBoard Membercurrent2025 — present
- BioVenture AdvisorsFounder and CEOcurrent2025 — presentNoblesville, Indiana, United States
- Latus BioCBO2025
- Orange Grove BioBoard Member2022 — 2024
- Eli Lilly and CompanyGlobal Head of Business Development | Lilly Catalyze2021 — 2024
- Eli Lilly and CompanyVP, Corporate Business Development - COVID-19, Genetic Medicines2019 — 2021
- Eli Lilly and CompanyVP, Corporate Business Development - Platforms, Digital Health, Emerging Markets2018 — 2019
- Eli Lilly and CompanySenior Director, Transactions – Corporate Business Development2016 — 2018
- Eli Lilly and CompanySenior Director - Channel Management, Trade & Specialty Group2013 — 2015Greater Indianapolis
- Eli Lilly and CompanySenior Director, National Payer Accounts2012 — 2013Greater Indianapolis
- Eli Lilly and CompanyDirector - Six Sigma Black Belt, Global Demand2010 — 2012
- Eli Lilly and CompanySenior Director, Business to Business Trade Accounts2008 — 2010
- Eli Lilly and CompanySenior Sales Representative - Diabetes2006 — 2008Greater Evansville Area
- Eli Lilly and CompanyDirector - B2B Strategy (Payer)2004 — 2006
- Eli Lilly and CompanySenior Associate - B2B Operations2003 — 2004
- Eli Lilly and CompanyChief Financial Officer - Lilly USA Functions2002 — 2003
- Eli Lilly and CompanyAssociate, Lilly USA Financial Analyst2001 — 2002
- Beta BionicsBoard Observer2021 — 2023
- Rodeo TherapeuticsBoard Member2018 — 2021
- Lodo Therapeutics CorporationBoard Observer2018 — 2021
- Accelerator Life Science PartnersBoard Observer2018 — 2021
- ApoGen Biotechnologies, Inc.Board Observer2018 — 2021
- Magnolia NeurosciencesBoard Observer2018 — 2021
- Proniras CorporationBoard Observer2018 — 2021
- Coba TherapeuticsBoard Observer2018 — 2019
Skills & more
Strategic Thinking4Value Creation4Pharmaceutical Industry68Pharmaceutical Sales45Strategy43Cross-functional Team Leadership19Product Launch17Market Access10Managed Care10Sales Effectiveness9Diabetes6Biotechnology5
+12 more
Six SigmaGlobal MarketingAccount ManagementMedical DevicesHealthcareOncologyCardiologyClinical TrialsLifesciencesLife SciencesBiopharmaceuticalsCommercializationFrom Katie's professional profile.
Colleagues at BlueYard Capital
Alejo Salles
Investor at BlueYard Capital
Antoaneta Mintcheva
Investor at BlueYard Capital
Chad Fowler
Partner at BlueYard Capital
Christine Fuchs
Investor at BlueYard Capital
Ciaran O'Leary
General Partner at BlueYard Capital
Cristel Mayer
Investor at BlueYard Capital
David Byrd
General Partner at BlueYard Capital
Jason Whitmire
General Partner at BlueYard Capital
Frequently asked questions
- Who is Katie Hewitt?
- Katie Hewitt is SVP Business Development and CBO Genetic Medicines at Alloy Therapeutics, Inc. She spent over 25 years at Eli Lilly, advancing from financial analysis to Global Head of Business Development for Lilly Catalyze, with roles spanning transactions, platform technology, and digital health. She has also served on the boards of biotechnology companies.
- Where does Katie Hewitt work?
- Katie Hewitt is at BlueYard Capital.
- Where did Katie Hewitt go to school?
- Katie Hewitt studied at Harvard Business School; DePauw University.
Same school
Also attended Harvard Business School2,000
Brad GerstnerFounder & CEO of Altimeter CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesJim BreyerFounder & CEO of Breyer CapitalTim DraperFounder of Draper AssociatesMike Maples JrCo-founding Partner at FloodgateMamoon HamidPartner at Kleiner Perkins
+ 1,994 more
Also attended DePauw University42
Mary MeekerFounder & General Partner at BONDMark TerbeekPartner at GreycroftRyan HaysBoard Member at CincyTechKatie McClainPartner & COO, Member of Investment Committee at Energize VenturesDaniel BarthPrincipal at Yamaha Motor VenturesStu SmithPartner at Scribble Ventures
+ 36 more
Shared employers
Also worked at Alloy Therapeutics, Inc.21
Jesse RobbinsFounder and Investor in AI Developer ToolsUlrik B. NielsenGeneral Partner at Mission BiocapitalChaya PatelPrincipal at Mission BiocapitalErrik AndersonBoard Director at Basecamp FundAlasdair ThongFounding Partner at Selvedge VentureEsra BerkolChief of Staff at Selvedge Venture
+ 15 more
Also worked at Eli Lilly and Company118
David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesNatalie FurneyGlobal General Counsel at Takeda VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios Capital
+ 112 more
